MoneyWorks4Me

Advik Lab - Quaterly Results

13 Oct 2021 Evaluate
A minor change in the total revenue was seen in the September 2021 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 0.00 millions during year ago period.The Net Loss for the quarter ended September 2021 is Rs. -0.12 millions as compared to Net Loss of Rs. -2.67 millions of corresponding quarter ended September 2020 Operating profit Margin for the quarter ended September 2021 improved to 0.99% as compared to -1.45% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.00
Other Income 2.54 0.09 2722.22 2.54 0.09 2722.22 1.95 0.11 1672.73
PBIDT 0.99 -1.45 -168.28 -0.68 -2.86 -76.22 -39.37 -6.63 493.82
Interest 0.01 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
PBDT 0.98 -1.45 -167.59 -0.69 -2.86 -75.87 -39.38 -6.63 493.97
Depreciation 1.28 1.42 -9.86 2.56 2.84 -9.86 5.56 5.73 -2.97
PBT -0.30 -2.87 -89.55 -3.25 -5.70 -42.98 -44.94 -12.36 263.59
TAX -0.18 -0.20 -10.00 -0.34 -0.40 -15.00 -0.78 -0.70 11.43
Deferred Tax -0.18 -0.20 -10.00 -0.34 -0.40 -15.00 -0.78 -0.70 11.43
PAT -0.12 -2.67 -95.51 -2.91 -5.30 -45.09 -44.16 -11.66 278.73
Equity 191.11 191.11 0.00 191.11 191.11 0.00 191.11 191.11 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -16575.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..